[ad_1]
Think of the underarms of your shirt during your most bustling summer day. Now, make them twice soaked in the middle of a cold winter day – this is what some people with hyperhidrosis have to do. Hyperhidrosis, known as excessive sweating can affect multiple areas of the body, but armpits are one of the most commonly complained points, not only because of sweating it same, but also because of the effect have on the clothes. Typically, when clinical strength antiperspirants are not enough to minimize armpit sweating, the treatments of the next stage have been limited, costly, and sometimes uncomfortable. However, a newly approved treatment can offer people with hyperhidrosis a new exciting non-invasive option.
Last week, the Food and Drug Administration (FDA) approved Qbrexza tissue, also known as glycopyrronium, for primary axillary topical therapy. hyperhidrosis – excessive underarm sweating – in patients nine years of age and older. It is an anticholinergic, which means that it blocks neurotransmitters and "works by blocking the signal from binding to the sweat glands," a New York-based dermatologist Joshua Zeicher recounts [19659009] Allure . "It is applied topically daily by the patient in the form of a wipe.It has the convenience of being applied at home and there is no discomfort associated with needles. "
Zeichner needles refer to these. 19659012] associated with Botox whose injections act by preventing a signal from being released from your nerves so that they do not stimulate your sweat glands, he explains. Another option at the office is MiraDry, a device that uses energy to destroy the sweat glands after numbing the underarm area of the patient. Qbrexza, however, does not need to be administered by a doctor. Once prescribed, it is up to the patient to apply the treatment each day.
"For years, dermatologists have been telling us about the need for new treatment options that address primary axillary hyperhidrosis given the stigma and burden associated with this disease." Tom Wiggans, president and CEO of Dermira, said in a press release . "From the start, our goal was to develop an approach that went beyond masking excessive armpit sweating and focused on treating the disease in a clinically meaningful way. We collaborated with dermatologists and the FDA during development and listened to people who have lived with this condition to understand how they would define a significant benefit.We hope that Qbrexza will not only provide the clinical benefit that these patients have sought, but will help reduce the overall burden of their lives. "[19659019] According to Zeichner, Qbrexza shows the promise to do just that." In clinical trials, patients experienced a reduction in sweating from their first office visit after a week, "he says to Allure Unfortunately, new patients will not be able to experience the reduction of sweating this summer, as Qbrexza is expected to be available in October.However, for someone who suffers from hyperhidrosis, relief from sweat is welcome at any time of the year.
For more information on Qbrexza, visit qbrexza.com
More info on sweatshirt:
19659027] Jonathan Van Ness and Queer Eye try nine things they have never done before:
Follow Marci on Instagram and Twitter or subscribe to the Allure newsletter [19659033] for daily beauty stories delivered directly to your inbox.
[ad_2]
Source link
